This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • An open-label treatment study to evaluate the safe...
Clinical trial

An open-label treatment study to evaluate the safety, tolerability and efficacy of AFQ056 in Parkinson�s patients with L-dopa induced dyskinesias

Read time: 1 mins
Last updated:24th Feb 2012
To evaluate the long-term safety and tolerability of AFQ056 in patients with PD-LID as assessed by �Incidence and severity of adverse events and serious adverse events �Changes in vital signs, laboratory assessments, and ECGs �Changes in underlying symptoms of PD as measured by the UPDRS (Unified Parkinson�s Disease Rating Scale) part III (Motor Examination) and AEs potentially related to an exacerbation of the movement disorder of PD
Category Value
Study start date 2012-02-24

View full details